3Fountas KN,Kapsalaki EZ,Parish DC,et al.Intraventricular administration of rt-PA in patients with intraventricular haemorrhage[J].South Med J,2005,98(8):767-773.
4Naff NJ,Hanley DF,Keyl PM,et al.Intraventricular thrombolysis speeds blood clot resolution:results of a pilot,prospective,randomized,double-blind,controlled trial[J].Neurosurgery,2004,54(3):577-584.
5Coplin WM,Vinas FC,Agris JM,et al.A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular haemorrhage[J].Stroke,1998,29(8):1573-1579.
6Naff NJ,Carhuapoma JR,Williams MA,et al.Treatment of intraventricular haemorrhage with urokinase.Effects on 30-day survival[J].Stroke,2000,31(4):841-847.
7Engelhard HH,Andrews CO,Slavin KV,et al.Current management of intraventricular hemorrhage[J].Surg Neurol,2003,60(1):15-22.
8Mayfrank L,Lippitz B,Groth M,et al.Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage[J].Acta Neurochir (Wien),1993,122(1-2):32-33.
10Spuck S,Konig IR,Arnold H,et al.Prospective studies in patients with intraventricular haemorrhage without the capacity to give consent in germany a legal dilemma[J].Zentralbl Neurochir,2006,67(4):183-187.
